Par prepares for IPO

CHESTNUT RIDGE, N.Y. — Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares offered by the company and its shareholders, along with the price, haven’t been determined, according to a statement from Par. 

 

J.P. Morgan and Goldman, Sachs & Co. are working as joint managers as well as representatives of the underwriters for the proposed IPO. Additionally, Citigroup, Morgan Stanley, BofA Merrill Lynch, Deutsche Bank Securities and Evercore ISI are joint book-running managers for the offering, according to Par.